France withdraws two Bayer HIV tests:
This article was originally published in Clinica
Executive Summary
The French Healthcare Products Safety Agency, AFSSAPS, has withdrawn two of Bayer's HIV tests from the market. The decision is based on the grounds that the sensitivity results of the assays - Serodia HIV and Serodia HIV 1/2 - were borderline and that it would be impossible to improve their performance. The tests are manufactured by Japan's Fujirebio and marketed in France by Bayer. The German company is not aware of the same products being banned in other countries in Europe. France banned six other HIV tests in June.